Kyle Moran - 05 Feb 2024 Form 4 Insider Report for Wave Life Sciences Ltd. (WVE)

Role
Chief Financial Officer
Signature
/s/ Kyle Moran
Issuer symbol
WVE
Transactions as of
05 Feb 2024
Transactions value $
$0
Form type
4
Filing time
07 Feb 2024, 19:05:11
Previous filing
23 Aug 2023
Next filing
05 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WVE Share Option (right to buy) Award $0 +372K $0.00 372K 05 Feb 2024 Ordinary Shares 372K $3.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 25% of the shares on February 5, 2025, and vests as to an additional 6.25% of the shares quarterly thereafter until February 5, 2028.